Big news from @ZipBio_Inc : we’ve entered an exclusive license agreement with @MeiraGTx to advance a first-in-class AAV gene therapy for Geographic Atrophy.
Combining AI protein design with deep gene therapy and ophthalmology expertise to unlock new treatment possibilities.
Congratulations to Dr. David Baker on the Nobel Prize in Chemistry!
We are proud to celebrate Dr. Baker’s groundbreaking contributions to protein design, which have transformed modern medicine. https://t.co/cHlpBiw1jb
Dr. Baker was the mentor and doctoral supervisor of our CTO, @Arielbs100. Our work continues to be deeply influenced by Dr. Baker’s vision, driving us to push the boundaries of protein design to tackle some of the most complex challenges in medicine.
We’re excited to announce the official launch of ZipBio! Our mission is to set a new standard for the development of biologics and gene therapies using generative AI.
https://t.co/Twhye2IsXh
Founded by @roee_farber, @Arielbs100, @ozelichov and Ori Hassin our COMPACT platform compresses complex biological structures into smaller, more efficient de novo-designed proteins that retain full functionality, optimizing delivery and therapeutic effectiveness.
Here's an interesting use of AI in drug design: making compact proteins. @ZipBio_Inc is shaving off the unimportant parts of proteins and using generative AI to fill in a backbone that holds the molecule together. Read more in my exclusive for @endpts: https://t.co/RPpqjRZa6J
The February issue, with a focus on protein engineering, is live https://t.co/5zL1A8zf3S
Our cover shows the three data types key to machine learning for functional protein design: structure, sequence and labels, from a Review by Notin et al. https://t.co/ZgfK6N0LD7
It's so satisfying to see our work in print! We showcase computer designed #protein#biomaterials engaging cells with molecular precision to decipher one of the most fundamental and yet elusive determinants of cell division process. Huge POC for the future of #synthetic_biology!